Resveratrol (Expanded) for Heart Health

Research suggests that resveratrol may offer protective benefits for heart health, primarily through its activation of SIRT1 and its broader antioxidant and anti-inflammatory properties shared with other polyphenols. The available evidence draws largely from animal studies, mechanistic laboratory research, and narrative or systematic reviews rather than large-scale human clinical trials, with findings generally pointing in a supportive direction — including one 2025 study in isolated rat hearts showing reduced ischemia/reperfusion injury through SIRT1 activation, and a 2014 review summarizing two decades of promising animal data on resveratrol's effects on heart structure and function. Studies indicate that some of the underlying biological pathways, such as insulin signaling in cardiac tissue and FoxO-driven feedback loops, are more complex than initially assumed, introducing nuance into the picture of how resveratrol acts in the heart. Overall, while the body of research is encouraging, its current limitations — including a relative scarcity of rigorous human trials and questions about bioavailability — mean that conclusions about resveratrol's clinical value for heart health remain preliminary.